Etrasimod Impurity 55 CAS CATO-C4X-321455
| CAS No. | CATO-C4X-321455 |
| Molecular Formula | C26H26F3NO4 |
| Molecular Weight | 473.48 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Etrasimod Impurity 55 is closely related to a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
Etrasimod Impurity 55 (CAS CATO-C4X-321455) is a certified pharmaceutical impurity reference standard with the molecular formula C26H26F3NO4 and a molecular weight of 473.48 g/mol.
Owing to a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution, Etrasimod Impurity 55 is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 473.48 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Etrasimod Impurity 55 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C26H26F3NO4 |
| Molecular Weight | 473.48 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | ≥95% |
| Storage | Store at room temperature, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 13.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 1 |
Related Etrasimod Standards
- Etrasimod impurity 18 (CAS CATO-C4X-321418)
- Etrasimod Impurity 24 (CAS CATO-C4X-321424)
- Etrasimod Impurity 25 (CAS CATO-C4X-321425)
- Etrasimod impurity 4 (CAS CATO-C4X-32144)
- Etrasimod Impurity 54 (CAS CATO-C4X-321454)
- Etrasimod Impurity 56 (CAS CATO-C4X-321456)
- Etrasimod Impurity 30 (CAS 1643579-27-4)
- Etrasimod impurity 1 (CAS 1206123-36-5)
Recommended Standards
- (4-((4-((Tert-butyldiphenylsilyl)oxy)piperidin-1-yl)methyl)phenyl)boronic acid (CAS 1704082-69-8)
- Capecitabine Impurity 22 (CAS CATO-C4X-102422)
- Moxifloxacin Impurity 60 (CAS CATO-C4X-107460)
- Penicillamine Impurity 32 (CAS CATO-C4X-29232)
- Perindopril Impurity 78 HCl (CAS CATO-C4X-125281)
- Ilaprazole Impurity 59 (CAS 1508282-87-8)
- Crisaborole Impurity 42 (CAS 1260761-47-4)
- 7-Chloro-4-(furan-3-yl)quinoline (CAS 179380-95-1)
- 2-Formylisoindoline-5-carboxylic acid (CAS 1566545-33-2)
- 1,2,3,4-Tetrahydroisoquinolin-4-amine (CAS 681448-81-7)
- (4-Methoxypyrazol-1-yl)-acetic acid (CAS 1784782-07-5)
- 5-(2-Fluorobenzylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione (CAS 23160-08-9)
- 3-Iodo-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one (CAS 1415638-01-5)
- Human glucagon CRS (CAS 9007-92-5)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com